UNITY Biotechnology to Participate in Upcoming March Investor Conferences
Tweet
Share
E-mailSOUTH SAN FRANCISCO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that members of its senior management team will participate in the following upcoming March virtual investor conferences:
Cowen 41st Annual Healthcare Conference Date: March 3, 2021Presentation Time: 1:20 p.m. ET
33rd Annual ROTH ConferenceDate: March 15, 2021Presentation Time: 4:00 p.m. ET
A live audio webcast of the presentations will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following each event.
About UNITYUNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.
Investors Gilmartin Group Matt Lane [email protected] Media Canale Communications Jason Spark [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Notification on regarding Interest Rates for the period
- Beam Global Battery Design for AI Data Centers Accepted for Presentation at IECON 2026
- Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
